logo
Celtics' Brad Stevens sends bold statement after Boston trades for St. John's RJ Luis Jr., signs Chris Boucher

Celtics' Brad Stevens sends bold statement after Boston trades for St. John's RJ Luis Jr., signs Chris Boucher

Yahoo3 days ago
Celtics' Brad Stevens sends bold statement after Boston trades for St. John's RJ Luis Jr., signs Chris Boucher originally appeared on The Sporting News
Boston Celtics President of Basketball Operations Brad Stevens is not punting on the 2025-26 NBA season after Jayson Tatum's potentially campaign-ending Achilles tear in May during their Eastern Conference Semifinals series against the New York Knicks. Boston lost in six games after losing Tatum in Game 4.
After his latest round of wheeling and dealing – one that followed a painful parting of ways from Kristaps Porzingis and Jrue Holiday in June – Stevens has built a team that's low on cost, but certainly not low on long, athletic players.
On Tuesday, ESPN's Shams Charania reported that the Celtics traded Georges Niang and a pair of future second-round picks to the Utah Jazz for rookie St. John's Red Storm product R.J. Luis Jr.
Luis is on a two-way contract.
In a subsequent move, the Cs signed Chris Boucher to a one-year, $3.3 million deal, per Charania.
In one fell swoop, Stevens offloaded an expiring contract to lower the tax bill, landed a high-ceiling rookie who costs nothing to employ or release, and signed a stretch/rim-protecting big for minimum money. One who wears a championship ring at that.
Stevens knows what winning looks like, two years removed from the franchise's 18th title.
His front office moved the needle in that direction, with or without Tatum in the lineup this coming season.
Derrick White, Anfernee Simons, Jaylen Brown, Boucher, and Neemis Queta can produce enough points and protect the rim well enough to compete for a postseason seed in a weak Eastern Conference. Especially with a second unit teeming with intriguing young talent like Luis, Baylor Scheierman, and Hugo González, with a mix of championship experience in Payton Pritchard and Sam Hauser. Assuming the latter two aren't moved as well.
The frontcourt leaves a bit to be desired still, but who knows what Stevens has cooking up next.
Boston will not just become a rebuilding team. Stevens gave Joe Mazzulla enough to keep their heads above water without Tatum.
With No. 0 back? All of a sudden, the Cs have a sky-high ceiling if enough things break right.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Boston Celtics Sign Head Coach Joe Mazzulla to Multi-Year Extension
Boston Celtics Sign Head Coach Joe Mazzulla to Multi-Year Extension

Fox News

timean hour ago

  • Fox News

Boston Celtics Sign Head Coach Joe Mazzulla to Multi-Year Extension

Boston Celtics president Brad Stevens has said throughout the offseason that the team wanted Joe Mazzulla to be its coach for a long time. It made that more than a proclamation Friday, announcing it has signed Mazzulla to a multi-year contract extension. Length and details of the new deal were not released. In a statement, Mazzulla called his new pact with the team "a blessing." "I would not be here without my faith, my wife, and my children," Mazzulla said. "We are thankful for the partnership with our ownership groups, Brad's mentorship, and the support of our staff. Most importantly, I am grateful for the players I have been able to coach the past three seasons. I look forward to competing for the Celtics and the city of Boston." Mazzulla, 37, is coming off his third season as Boston's coach and has guided the team to the playoffs each season, including the franchise's 18th NBA title to cap the 2023-24 season. He was the youngest head coach to win the NBA Finals since the 1968-69 season, when 35-year-old Bill Russell led the Celtics to the championship as a player-coach. Under Mazzulla, the Celtics have won at least 57 games each of those seasons and topped 60 victories in each of the last two. Though Stevens has never publicly discussed the details of Mazzulla's contract, the coach was initially given an extension shortly after having the interim tag lifted in February 2023. Stevens confirmed in June that Mazzulla had received at least one additional extension prior to his latest one. "He understands the job and has a passion for the Celtics that is only rivaled by our most die-hard fans," Stevens said in a statement. "He's worked hard and accomplished amazing things in his first three years as a head coach — including averaging over 60 wins per season and winning the 2024 NBA Championship. Joe is a gifted leader who brings a consistent commitment to learning, improving, and maximizing each day we get to compete for the Boston Celtics." Mazzulla originally joined the Celtics in 2019 and spent the next three seasons as an assistant before becoming interim head coach after former boss Ime Udoka was suspended by the team prior to the start of the 2022-23 season. Reporting by The Associated Press. Want great stories delivered right to your inbox? Create or log in to your FOX Sports account, and follow leagues, teams and players to receive a personalized newsletter daily!

MLB Roundtable: Worry Time For Kyle Tucker? Roman's Red Sox Deal A Risk?
MLB Roundtable: Worry Time For Kyle Tucker? Roman's Red Sox Deal A Risk?

Fox News

timean hour ago

  • Fox News

MLB Roundtable: Worry Time For Kyle Tucker? Roman's Red Sox Deal A Risk?

The Red Sox are entering a Roman reign, but is Boston's big move worth the price? In this week's roundtable, FOX Sports MLB reporters Rowan Kavner and Deesha Thosar answer that question, look at Kyle Tucker's summer struggles, and pick which contender team could fade in the fall. But let's first start out West with the enigmatic A's. 1. The Athletics can't pitch, and that's why they sit in last place in the AL West. But their lineup, including Nick Kurtz and Shea Langeliers, has been fantastic. Are the A's quietly some better pitching away from contending? Kavner: There were some who picked the A's as a dark-horse team to make the playoffs before the season based on the young talent in place on the offensive side, and while that prognostication doesn't look too good now, the growth of those pieces suggests that even a mediocre pitching staff could help them contend soon. Now, finding a way to entice pitchers to go to a minor league ballpark — let alone one where the ball flies the way it has at Sutter Health Park — was going to be difficult even before Luis Severino posted his stark home (1-9, 6.34 ERA) and road (5-2, 3.17) splits, which might scare prospective free agents off even more. But, maybe some pitchers will overlook that when they see the potential in a roster that includes an All-Star starting shortstop in Jacob Wilson, the best hitter in baseball over the last two months in Kurtz, plus Langeliers, Brent Rooker, Lawrence Butler and Tyler Soderstrom, a group that should mash for years to come. If the prospects in the Mason Miller trade pan out, too, brighter days could be ahead in the not-too-distant future. Thosar: Kurtz is the frontrunner for the AL Rookie of the Year award after his eye-popping four-homer game a couple of weeks ago, and right behind him is teammate Jacob Wilson, whose 119 wRC+ is third-best among AL rookies, trailing only Kurtz and Boston's Roman Anthony. The A's have three hitters in the AL's top 30 (Brent Rooker, Tyler Soderstrom, and Wilson) in terms of wRC+, which paints an offense that's in line with most playoff contenders — better even than Detroit, Boston, and Houston overall. But their pitching staff is not only ranked the worst in the AL, it's also 28th in MLB. That was to be expected, since it will continue to be difficult to entice quality arms to pitch in the hitter-friendly Sutter Health Park, short of offering them an outrageous contract (though that hasn't worked out so well for Luis Severino, either). So, yes, the A's could contend for the playoffs with better pitching, but given their ballpark situation for at least the next 3-4 years, it's a bleak outlook. 2. The Brewers were the first team to 70 wins, partly due to in-season pickup Andrew Vaughn. Is he genuinely a better hitter now than he was with the White Sox? Kavner: After watching Gavin Sheets put up his best season as a pro in his first year after leaving Chicago, it doesn't seem too far-fetched that a player with the raw power and pedigree of Vaughn, a former Golden Spikes Award winner at Cal and No. 3 overall pick, would find another level with a fresh start on a contending team. Now, no one could've anticipated this kind of dramatic turnaround this quickly. Is he all of a sudden one of the best hitters in MLB and a 1.000+ OPS guy the rest of the year in Milwaukee? Probably not, but the underlying numbers suggest this upswing isn't just a fluke. With a faster yet more compact swing, he's managing to hit the ball harder and get to his pull-side power while cutting his strikeout rate almost in half from what it was with the White Sox. The sample size is still small, but this is the best 22-game stretch of his career. Even if he doesn't stay this hot, there are reasons to believe he's a better hitter now than what we had seen to this point in his career. Thosar: Not even the Brewers could've anticipated that Vaughn would go from hitting .211 in Triple-A at the time they traded for him, to becoming the scariest hitter in Milwaukee's lineup a month later. I mean, the difference in his production with Chicago is staggering. Vaughn slashed .189/.218/.314 with five home runs, seven walks, and 19 RBIs in 48 games with the White Sox this season before they demoted him to the minors at the end of May. Jump forward to today, and he's slashing .377/.444/.701 with seven home runs, 10 walks, and 28 RBIs in 22 games with the Brewers. The 27-year-old said he hasn't tinkered with his swing or approach since getting traded, but there are obvious differences, including his newfound plate discipline. If Vaughn can continue to command the zone and cut down on his chase rate and strikeouts, then the underlying power numbers have always been there to suggest this version of Vaughn, particularly stretched out over the second half of the season, can be sustainable. 3. Roman Anthony just got paid by the Red Sox with a $130 million extension that could escalate to $230 million. Do you see this move for the rookie as an aggressive one, or just right? Kavner: I think it's a prudent move for a surging Red Sox team that traded away Rafael Devers, did little of note at the deadline and understands the pain of watching homegrown superstars leave town. From Brayan Bello to Ceddanne Rafaela to Kristian Campbell, the Red Sox have been proactive in finding ways to keep their young talents through what would have been their early free-agent years. The MVP ceiling is higher in Anthony than any of the aforementioned players, which is reflected in the total value of the new contract. The team assumes some risk, considering Anthony is not even 50 games into his big-league career, but the 21-year-old phenom with preternatural plate discipline and a penchant for hard hits is already batting 26% better than league average and playing above-average outfield defense. Rather than watch him reach his potential and then sign a Juan Soto or Vladimir Guerrero Jr. type of deal at 26, the Red Sox now ensure he'll be in Boston throughout his 20s. Anthony's already a top-of-the-lineup force, and if he starts to lift the ball more often, he possesses all the tools to develop into one of the most feared hitters in the game. Thosar: This was a smart move by the Red Sox, especially when you consider the climate in which they did it. The heat was turned all the way up on Craig Breslow and John Henry after trading away homegrown slugger Rafael Devers, and it brought back depressing memories of when the Red Sox failed to sign Mookie Betts to a long-term contract. So when the opportunity came to lock up Roman Anthony long-term, Boston moved quickly in part to get back in the good graces of the fanbase, and to lay the groundwork for the 21-year-old to become the next homegrown star. Not even 50 games into his major-league career, Anthony is a strong contender to finish second in AL Rookie of the Year voting, which means he would earn a full year of service time. In that case, the Red Sox' extension buys out three free-agent years, all while ensuring that Anthony can no longer maximize what he could make in his arbitration. After so much of what this front office has done has been puzzling, this is a deal that makes sense. 4. Is it time to start worrying about Kyle Tucker? The slugger has hit just one home run since July 1, and is batting .208/.353/.271 in that stretch. Kavner: My main concern is whether he's playing hurt. He exited a game with a finger injury on June 1. To that point, he had a .524 slugging percentage, a .918 OPS and an 11.9% strikeout rate. Since then, he has a .413 slugging percentage, a .786 OPS and a 17.5% strikeout rate. He also missed a couple games after fouling a ball off his knee on July 22 and has a .685 OPS with two extra-base hits in 11 games since. It's possible this is just a blip in yet another sensational season. In 2023, he had a .681 OPS in May and an OPS over .850 every other month. In 2022, he had a .625 OPS in July and followed that up with a .921 OPS the following month. These things can happen, but the precipitous drop-off does have me wondering how healthy he is. Thosar: It's surprising to think Tucker has been a below-league average hitter since July 1 (.624 OPS, 91 wRC+), which is his worst-career 28-game stretch since May 2023, when he recorded a .681 OPS. But Tucker has gone through these stretches when he's played full seasons. In July 2022, he posted a .625 OPS and rebounded for a .921 OPS in August. In April 2021, he had a .610 OPS and then he hit a groove for a .940 OPS the following month. Those are all the years that Tucker has played 100+ games, including this season. So, his history tells us a dip in his numbers is par for the course when he's on pace to finish the season with a minimum of 140 games played. That theory will be proven right if he picks up his production over this next week or so. If not, then it's fair to question whether the finger injury Tucker sustained on June 1 could be affecting him more than he's admitting. Still, I wouldn't start worrying about the four-time All-Star unless the past month's slump trickles into, say, September. 5. Prediction time! Name one team currently holding onto a playoff spot that will fumble it before the season's end. Kavner: Is it too boring if I say the current playoff field is the one we'll see in October? All right, fine, fine, that's no fun. As tempting as it is to pick one of the New York teams here, I'll say the Astros. Their first half was incredible considering all the injuries they had weathered, but we're starting to see the cracks in their depleted roster. They have a losing record since the start of July, the Mariners might now be the most talented team in the American League after beefing up at the deadline, and the Rangers have finally started to wake up. A lot of Houston's pieces are expected back in the second half, but who knows how long it will take for them to get back up to speed — or where the Astros will be in the standings when those reinforcements arrive. Thosar: So much can change in the next seven-plus weeks, but if we're looking at recent trends… It's the Mets. Among the 12 teams currently holding onto playoff spots, the Mets have the second-worst run differential (+35), behind only the Mariners (+30). But Seattle just significantly improved at the trade deadline with the additions of Eugenio Suarez and Josh Naylor, and it enters Friday having won seven of its last 10 games. The Mets, on the other hand, have won only two of their last 10 games and focused on beefing up their bullpen (albeit with splashy, substantial pickups) rather than addressing their weaknesses in the rotation and lineup (sorry — adding Cedric Mullins isn't a major offensive upgrade). New York's new and improved bullpen can't save games if the offense doesn't give their relievers a lead. That being said, you'd think the top three of Juan Soto, Francisco Lindor and Pete Alonso will have to wake up at some point. But, until they do, the Mets are on their way to fumbling this. Rowan Kavner is an MLB writer for FOX Sports. He previously covered the L.A. Dodgers, LA Clippers and Dallas Cowboys. An LSU grad, Rowan was born in California, grew up in Texas, then moved back to the West Coast in 2014. Follow him on Twitter at @RowanKavner. Deesha Thosar is an MLB writer for FOX Sports. She previously covered the Mets as a beat reporter for the New York Daily News. The daughter of Indian immigrants, Deesha grew up on Long Island and now lives in Queens. Follow her on Twitter at @DeeshaThosar.

Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025
Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025

Yahoo

time2 hours ago

  • Yahoo

Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025

BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended June 30, 2025 and host a webcast and conference call to provide an update on the ongoing tovecimig Phase 2/3 study, clinical data for CTX-8371 and preclinical data for CTX-10726, on Monday, August 11, 2025, at 8:00 a.m. ET. Call Details: Date: Monday, August 11, 2025 Time: 8:00 AM ET Webcast: Dial-In: 1-877-407-9716 (US), 1-201-493-6779 (International), 13754954 (Conference ID) Virtual/Replay availability: A replay will be archived for 90 days on Compass' Events page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The Company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at Investor Contactir@ ContactAnna Gifford, Chief of Staffmedia@ lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store